Abstract
At the present time, approx. 1–2% of the population of the Western world contract cardiac insufficiency, usually therapy-resistant and terminal. Orthotopic heart transplantation (HT) represents the only currently available curative form of therapy with a justifiable 5-year survival prognosis (Ref. 12). The growing mismatch between donor pool and recipient group has provoked constant discussion about the criteria for inclusion and exclusion in these groups (Refs. 18, 28). Whereas in the initial stages of HT recipient age and concomitant diseases were crucial criteria for recipient selection, improved chances of survival caused these criteria to be relaxed (Ref. 12). Biological age is becoming more and more predominant in the selection of recipients. Concomitant diseases, such as diabetes mellitus, hepatitis B/C, secondary amyloidosis, condition following neoplasia beyond the 5-year recurrence rate no longer represent contraindications (Refs. 23, 26, 16, 17). Current contraindications for orthotopic HT include fixed pulmonary hypertension (>5 Wood units), active acute infections and HIV infections.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abraham WT, Bristow MR (1997) Specialized centers for heart failure management. Circulation 96:2755–2757
Bailey CL, Nehlsen-Cannarella SL, Conception W, Jolley WB (1985) Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 254:3321–3329
Batista RJV, Santos JLV, Takeshita N, Bocchino Lise, Lima PN, Cunha MA (1996) Partial left ventriculectomy to improve left ventricular function in end-stage heart disease. J Card Surg 11:96–97
Brown G, Albers JJ, Fisher LD, et al. (1990) Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein. N Engl J Med 323:1289–1298
Cazeau S, Ritter P, Bakdach S, Lazarus A, Limousin M (1994) Four chamber pacing in dilated cardiomyopathy. PACE 17:1974–1979
Chachques JC, Berrebi A, Hernigou A, Cohen-Solal A, Lavergne T, Marino J-P, D’Attellis N, Bensasson D, Carpentier A (1997) Study of muscular and ventricular function in dynamic cardiomyoplasty: A ten-year follow-up. J Heart Lung Transplant 16:854–868
Czaplicki J, Blonska B, Religa Z (1992) The lack of hyperacute xenogeneic heart transplant rejection in a human (letter). J Heart Lung Transplant 11:393–397
Dickstein ML, Spotnitz HM, Rose EA, Burkhoff D (1997) Heart reduction surgery: an analysis of the impact on cardiac function. J Thorac Cardiovasc Surg 113:1032–1040
Hardy JD, Chavez CM, Kurrus FD, Neely WA, Eraslan S, Turner MD, Fabian LW, Labecki TD (1964) Heart transplantation in man: Developmental studies and report of a case. JAMA 188:1132–1140
Hochleitner M, Hoertnagl H, Choi-Keung Ng, et al. (1990) Usefulness of physiological dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 66:198–202
Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K, Lansing A, Mannting F, March R, Mirhoseini MR, Smith C (1997) Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 113:645–654
Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP (1996) The Registry of the International Society for Heart and Lung Transplantation: Thirteenth Official Report - 1996, J Heart Lung Transplant 15:655–674
Koerner MM, El Banayosy A, Posival H, Gromzik H, Koerfer R (1990) Ventricular assist device (VAD) systems combined with continuous high volume venous-venous hemofiltration (CVVH). Intensivbehandlung 15 Suppl.:A 104
Koerner MM, Tenderich G, Minami K, El-Banayosy A, Koertke H, Mannebach H, Bailer D, Kleesiek K, Gleichmann U, Koerfer R (1996) Rare indication: heart transplantation in recipients aged 70 years and older. Cardiology in the Elderly 4:171–175
Koerner MM, Tenderich G, Mannebach H, Minami K, El-Banayosy A, Koertke H, Wlost S, Gromzik H, Kleesiek K, Meyer H, Gleichmann U, Koerfer R (1996) Heart transplantation at the Heart Center North Rhine-Westphalia in Bad Oeynhausen - 1995 Report. In Clinical Transplants 1995. Edited by Terasaki J, Cecka JM. Los Angeles: UCLA Tissue Typing Laboratory 137–144
Koerner MM, Tenderich G, Minami K, zu Knyphausen E, Mannebach H, Kleesiek K, Meyer H, Koerfer R (1997) Heart transplantation for end-stage heart failure caused by iron overload. B J Haematol 97:293–296
Koerner MM, Tenderich G, Minami K, Mannebach H, Koertke H, zu Knyphausen E, El-Banayosy A, Baller D, Kleesiek K, Gleichmann U, Meyer H, Koerfer R (1997) Results of heart transplantation in patients with preexisting malignancies. Am J Cardiol 79:988–991
Koerner MM, Tenderich G, Posival H, Minami K, Mannebach H, zu Knyphausen E, Thies WR, Kleesiek K, Gleichmann U, Meyer H, Koerfer R (1995) Rare indication and long-term results after heart transplantation, In: Current aspects and concepts of nursing, coordinating, bridging and rehabilitation in organ transplantation. Excerpta medica, Koerner MM, Koerfer R (eds) Elsevier Science B.V., Amsterdam, pp. 213–230
Koerner MM, Tenderich G, El-Banayosy A, Minami K, Mannebach H, Meyer H, Koerfer R (1996) Longterm results of heart transplantation after use of ventricular assist devices. J Heart Lung Transplant 15 (suppl):S 86
Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE (1996) Long-term intermittend urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A randomized dose-response trial. J Am Coll Cardiol 27:575–584
McCarthy PM, Starling RC, Smedira NG, Buda TM, Scalia GM, Young JB (1997) Partial ventriculectomy with valve repair as an alternative to cardiac transplantation. J Heart Lung Transplant 16:A41
Mehta SM, Aufiero TX, Pae WE Jr, Miller CA, Pierce WS (1995) Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: sixth official report - 1994. J Heart Lung Transplant 14:584–593
Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Costanzo MR (1995) Report of the Consensus Conference on Candidate Selection for Heart Transplantation - 1993. J Heart Lung Transplant 14:562–571
Mirhoseini M, Cayton MM (1981) Revascularization of the heart by laser. Microsurgery 2:253–260
Moosdorf R, Schoebel F-C, Hort W (1997) Transmyokardiale Laserrevaskularisation - morphologische, pathophysiologische und historische Grundlagen der indirekten Revaskularisation des Herzmuskels. Z Kardiol 86:149–164
Mudge GH, Goldstein S, Addonizio LJ, Caplan A, Mancini D, Levine TB, Ritsch ME, Stevenson LW (1993) Task Force 3: Recipient guidelines/Prioritization. JACC 22:1–64
Murphy FA (1996) The public health risk of animal organ and tissue transplantation into humans. Science 273:746–747
Novitzky D (1996) Selection and managment of cardiac allograft donors. Current Opinion in Cardiology 11:174–182
Patel HJ, Lankford EB, Polidori DJ, Pilla JJ, Plappert T, Sutton MStJ, Acker MA (1997) Dynamic cardiomyoplasty: its chronic and acute effects on the failing heart. J Thorac Cardiovasc Surg 114:169–178
Pierce WS, Sapirstein JS, Pae WE (1996) Total artificial heart: from bridge to transplantation to permanent use. Ann Thorac Sur 61:342–346
Rector TS, Benditt D, Chachques JC, Chiu R C-J, Delahaye F, Jessup M, Kirkorian G, Thiene G (1997) Titus J for the Worldwide Cardiomyoplasty Group, Retrospective analysis for early heart-related death after cardiomyoplasty. Heart Lung Transplant 16:1018–1025
Replogle RL, Kaiser GC (1997) Left ventricular reduction surgery (Society position paper). Ann Thorac Surg 63:909–910
Stoye J et al. (1997) Two sets of human-tropic pig retrovirus (letter), Nature 389:681–682
Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW (1995) Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 92:3273–3281
United Network for Organ Sharing (1996) Update: Listing Criteria Approved for Public Comment. Vol 12. Washington, DC: UNOS pp. 8
Vineberg A (1954) Clinical and experimental studies in the treatment of coronary artery insufficiency by internal mammary artery implant. J Int Coll Surg 22:503–518
Oosterga M, ten Vaarwerk IAM, DeJongste MJL, Staal MJ (1997) Spinal cord stimulation in refractory angina pectoris - Clinical results and mechanisms. Z Kardiol 86:107–113
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Koerner, M.M., Tenderich, G., Koerfer, R. (1998). Borderline Indications for Heart Transplantation and Alternative Measures. In: Klein, M., Schulte, H.D., Gams, E. (eds) TMLR Management of Coronary Artery Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72134-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-72134-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72136-6
Online ISBN: 978-3-642-72134-2
eBook Packages: Springer Book Archive